SCHEMBL7681595

SCHEMBL7681595

COc1nc2cc(Cl)c(Cl)c(-c3nnn(C)c3-c3ccccc3)c2nc1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I3 Q14994 2/20 0.37
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
VDR P11473 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2B6 P20813 1/20 0.33
AHR P35869 1/20 0.33
RORC P51449 2/20 0.33
TRPM8 Q7Z2W7 1/20 0.32
PTGES O14684 1/20 0.32
SQOR Q9Y6N5 1/20 0.32
MAT2A P31153 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
NQO2 P16083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7683114 0.91 SMN1; SMN2 (0.38) NR1I3NPC1NFKB1RAB9ANFKB2
SCHEMBL27555336 0.87 NPC1 (0.36) NR1I3NPC1NFKB1RAB9ANFKB2
SCHEMBL7673858 0.81 RORC (0.31) NR1I3RORC
SCHEMBL7680558 0.81 SMN1; SMN2 (0.37) NR1I3NPC1NFKB1RAB9ANFKB2
SCHEMBL27413977 0.80 SMN1; SMN2 (0.39) NR1I3NPC1NFKB1RAB9ANFKB2
SCHEMBL7675073 0.77 NPC1 (0.36) NR1I3NPC1NFKB1RAB9ANFKB2
SCHEMBL7672900 0.76 RORC (0.31) NR1I3NPC1NFKB1RAB9ANFKB2
SCHEMBL15958641 0.75 KDM4E (0.45) NR1I3NPC1NFKB1RAB9ANFKB2
SCHEMBL7681496 0.74 SMN1; SMN2 (0.43) SMN1; SMN2CYP1A2HRH4
SCHEMBL7678666 0.72 RORC (0.33) NR1I3NPC1NFKB1RAB9ANFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed